OUR TEAM

Daniela Soriano Pignataro, M.D., Ph.D.

Vice President, Clinical Development

Daniela is a hematologist/oncologist by training and has over twelve years of global clinical drug development experience. She brings a strong clinical research background spanning Phase 1 to Phase 3 trials in both academia and industry, including work on small molecules, bispecific antibodies, ADCs, and CAR T-cell therapy in hematological malignancies and solid tumors. During her pharmaceutical career, she worked for large pharmaceutical companies such as Roche/Genentech, Pfizer, and AstraZeneca, as well as smaller biotech firms including Autolus and Apollo Therapeutics. She holds specialist registration as a hemato-oncologist in the UK and also has professional experience working as a hematologist/oncologist in university hospitals in London.